Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Patients with chronic kidney disease"'
Publikováno v:
Psikohumaniora: Jurnal Penelitian Psikologi, Vol 4, Iss 1, Pp 13-26 (2019)
Chronic Kidney Disease (CKD) not only affects the physical condition but also impacts on psychological conditions, such as feeling down, embarrassed by appearance, feelings of worthlessness, anxiety, to despair which is the cause of decreased quality
Externí odkaz:
https://doaj.org/article/9c827331a9c7407bbbe6229e87a9d045
Publikováno v:
Počki, Vol 6, Iss 3, Pp 155-159 (2017)
The ratio of uricemia, magnesia, quality of life and functional reserve of the kidneys in CKD has not been completely determined yet. These rates were analysed in 145 patients, depending on the CKD 1–5 stages. The dynamics in hyperuricemia, magnesi
Externí odkaz:
https://doaj.org/article/429ad465b51f4b018c22f607d0bf2544
Publikováno v:
International Urology and Nephrology. 54:349-356
Purpose: Patients with chronic kidney disease (CKD) usually represent an aging population, and both older age and CKD are associated with a higher risk of falling. Studies on risk factors among subjects with CKD are lacking. Methods: Records of outpa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2ebc655aa92a7c7223fe8e851fafd9
https://doi.org/10.1007/s11255-021-02884-w
https://doi.org/10.1007/s11255-021-02884-w
Background-\ud \ud Excessive daytime sleepiness (EDS) is prevalent in not only older adults, but also patients with chronic kidney disease (CKD), and is associated with higher risks of morbidity and mortality.\ud \ud Aims-\ud \ud The aim of the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9202a6cac922b7b74906784043cf54
https://arro.anglia.ac.uk/id/eprint/706838/10/Heybeli_et_al_2021.pdf
https://arro.anglia.ac.uk/id/eprint/706838/10/Heybeli_et_al_2021.pdf
Publikováno v:
1. Barrera-Vargas A, Quintanar-Martínez M, Merayo-Chalico J, Alcocer-Varela J, Gómez-Martín D. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case–control study. Rheumatology. 21 de septiembre de 2015;kev349.
2. Mattos P, Santiago MB. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol. junio de 2012;31(6):897-905.
3. Irene Carrión-Barberà, Tarek Carlos Salman-Monte, F. Vílchez-Oya, Jordi Monfort, Neuropsychiatric involvement in systemic lupus erythematosus: A review, Autoimmunity Reviews, Volume 20, Issue 4, 2021, 102780.
Miyawaki, Y., Shimizu, S., Ogawa, Y. et al. Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Res Ther 23, 79 (2021).
5. Damrongpipatkul, U., Oranratanachai, K., Kasitanon, N., Wuttiplakorn, S., & Louthrenoo, W. (2017). Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. Clinical Rheumatology, 37(3), 691–702. doi:10.1007/s10067-017-3892-2
6. Cardiel MH, Soriano ER, Bonfá ESD de O, Alarcón GS, Izcovich A, Amigo Castañeda MC, et al. Therapeutic Guidelines for Latin American Lupus Patients: Methodology. JCR J Clin Rheumatol. diciembre de 2017;1.
Gómez-Puerta JA, Cervera R. Lupus eritematoso sistémico. Med Lab. 2008;14(5):211–23.
8. Lee PT, Fang HC, Chen CL, Chiou YH, Chou KJ, Chung HM. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus. 2003:12 (11):827–832
9. Goo YS, Park HC, Choi HY, Kim BS, Park YB, Lee SK et al. The evolution of lupus activity among patients with endstage renal disease secondary to lupus nephritis. Yonsei Med J. 2004:45(2):199–206
11. Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2005:20(12):2797–2802
12. Inda-Filho A, Neugarten J, Putterman C, Broder A. Improving Outcomes in Patients with Lupus and End-Stage Renal Disease. Semin Dial. septiembre de 2013;26(5):590-6.
13. Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319–323.
14. Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Clin Exp Rheumatol. 2013;31:31–39.
15. Kang SH, Chung BH, Choi SR, Lee JY, Park HS, Sun IO et al. Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med. 2011:26(1):60–67
16. 59ª Asamblea General. Declaración de Helsinki. Seúl, Corea, octubre de 2008.
17. Ministerio de Salúd de la República De Colombia. De los aspectos éticos de la investigación en séres humanos. Resolución Número 8430. 1993:1:2-5.
18. Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. marzo de 2016;76(4):459-83.
19. Zhang Y, Han H, Chu L. Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey. Clinics. 2020;75:e1515.
20. Nayak-Rao, S, and M P Shenoy. “Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?.” Indian journal of nephrology vol. 27,3 (2017): 167-171.
21. Almannai M, Al Mahmoud RA, Mekki M, El-Hattab AW. Metabolic Seizures. Front Neurol. 2021;12:985.
22. Guenzani, D., Buoli, M., Carnevali, G. S., Serati, M., Messa, P., & Vettoretti, S. (2018). Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? Psychology, Health & Medicine, 23(8), 970–979.
23. Kivity, S., Agmon-Levin, N., Zandman-Goddard, G. et al. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med 13, 43 (2015).
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
2. Mattos P, Santiago MB. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol. junio de 2012;31(6):897-905.
3. Irene Carrión-Barberà, Tarek Carlos Salman-Monte, F. Vílchez-Oya, Jordi Monfort, Neuropsychiatric involvement in systemic lupus erythematosus: A review, Autoimmunity Reviews, Volume 20, Issue 4, 2021, 102780.
Miyawaki, Y., Shimizu, S., Ogawa, Y. et al. Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Res Ther 23, 79 (2021).
5. Damrongpipatkul, U., Oranratanachai, K., Kasitanon, N., Wuttiplakorn, S., & Louthrenoo, W. (2017). Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. Clinical Rheumatology, 37(3), 691–702. doi:10.1007/s10067-017-3892-2
6. Cardiel MH, Soriano ER, Bonfá ESD de O, Alarcón GS, Izcovich A, Amigo Castañeda MC, et al. Therapeutic Guidelines for Latin American Lupus Patients: Methodology. JCR J Clin Rheumatol. diciembre de 2017;1.
Gómez-Puerta JA, Cervera R. Lupus eritematoso sistémico. Med Lab. 2008;14(5):211–23.
8. Lee PT, Fang HC, Chen CL, Chiou YH, Chou KJ, Chung HM. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus. 2003:12 (11):827–832
9. Goo YS, Park HC, Choi HY, Kim BS, Park YB, Lee SK et al. The evolution of lupus activity among patients with endstage renal disease secondary to lupus nephritis. Yonsei Med J. 2004:45(2):199–206
11. Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2005:20(12):2797–2802
12. Inda-Filho A, Neugarten J, Putterman C, Broder A. Improving Outcomes in Patients with Lupus and End-Stage Renal Disease. Semin Dial. septiembre de 2013;26(5):590-6.
13. Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319–323.
14. Moon SJ, Park HS, Kwok SK, Ju JH, Kim HY, Park SH. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis. Clin Exp Rheumatol. 2013;31:31–39.
15. Kang SH, Chung BH, Choi SR, Lee JY, Park HS, Sun IO et al. Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med. 2011:26(1):60–67
16. 59ª Asamblea General. Declaración de Helsinki. Seúl, Corea, octubre de 2008.
17. Ministerio de Salúd de la República De Colombia. De los aspectos éticos de la investigación en séres humanos. Resolución Número 8430. 1993:1:2-5.
18. Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs. marzo de 2016;76(4):459-83.
19. Zhang Y, Han H, Chu L. Neuropsychiatric Lupus Erythematosus: Future Directions and Challenges; a Systematic Review and Survey. Clinics. 2020;75:e1515.
20. Nayak-Rao, S, and M P Shenoy. “Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?.” Indian journal of nephrology vol. 27,3 (2017): 167-171.
21. Almannai M, Al Mahmoud RA, Mekki M, El-Hattab AW. Metabolic Seizures. Front Neurol. 2021;12:985.
22. Guenzani, D., Buoli, M., Carnevali, G. S., Serati, M., Messa, P., & Vettoretti, S. (2018). Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? Psychology, Health & Medicine, 23(8), 970–979.
23. Kivity, S., Agmon-Levin, N., Zandman-Goddard, G. et al. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med 13, 43 (2015).
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
El lupus eritematoso sistémico (LES) es una enfermedad autoinmune y crónica de causa aún desconocida (1). El compromiso neuropsiquiátrico es una complicación relativamente frecuente durante la actividad lúpica y se caracteriza por síndromes ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2518d0b94328e5fbc5a796e1a845bbb7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
KIDNEYS; Том 6, № 3 (2017); 155-159
Почки-Počki; Том 6, № 3 (2017); 155-159
Нирки-Počki; Том 6, № 3 (2017); 155-159
Почки-Počki; Том 6, № 3 (2017); 155-159
Нирки-Počki; Том 6, № 3 (2017); 155-159
Соотношение урикемии, магниемии, качества жизни и функционального резерва почек при хронической болезни почек (ХБП) окончательно не опр
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=scientific_p::c8156d2942ea15b1bfb7f5dda6d91bbf
http://kidneys.zaslavsky.com.ua/article/view/109031
http://kidneys.zaslavsky.com.ua/article/view/109031
About 30-40% of patients with chronic kidney disease (CKD) patients also have concomitant diabetes (1). Diabetes has been shown to have signifi cantly stronger association with CKD in patients with younger age (2). Diabetes management in CKD poses si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbdc17df95f3e02eeec08e7a54991adc
https://zenodo.org/record/1625756
https://zenodo.org/record/1625756
Hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis, can be ameliorated by oral phosphate binders in conjunction with dietary phosphate restriction. Although phosphate binders reduce serum phosphate in these pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f5705c993942144b995746872b082c
https://europepmc.org/articles/PMC5313253/
https://europepmc.org/articles/PMC5313253/
Publikováno v:
Psikohumaniora: Jurnal Penelitian Psikologi, Vol 4, Iss 1, Pp 13-26 (2019)
Chronic Kidney Disease (CKD) not only affects the physical condition but also impacts on psychological conditions, such as feeling down, embarrassed by appearance, feelings of worthlessness, anxiety, to despair which is the cause of decreased quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::870a63b2abb9b2655b717b75c49911a5
https://doi.org/10.21580/pjpp.v4i1.3332
https://doi.org/10.21580/pjpp.v4i1.3332